Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice

Immunology

Volumn 92, Issue 2, 1997, Pages 206-213

  Kobata, T ^a,b   Takasaki, K ^a   Asahara, H ^a   Mai Hong, N ^a   Masuko Hongo, K ^a   Kato, T ^a   Hirose, S ^b   Shirai, T ^b   Kayagaki, N ^b   Yagita, H ^b   Okumura, K ^b   Nishioka, K ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; ETIOLOGY; GENE EXPRESSION; HYPERGAMMAGLOBULINEMIA; IMMUNOLOGICAL TOLERANCE; LIGAND BINDING; LYMPH NODE; LYMPHOCYTOTOXICITY; LYMPHOID HYPERPLASIA; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR BINDING; SPLEEN CELL; THERAPY; THYMUS;

EID: 9844254486     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00347.x     Document Type: Article

References (29)

1. LYNCH D.H., RAMDELL F. & ALDERSON M.R. (1995) Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16, 569.
2. NAGATA S. & SUDA T. (1995) Fas and Fas ligand: lpr and gld mutations. Immunol Today 16, 39.
3. COHEN P.L. & EISENBERG R.A. (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9, 243.
4. TAKAHASHI T., TANAKA M., BRANNAN C.I. et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969.
5. LYNCH D.H., WATSON L.M., ALDERSON M.R. et al. (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1, 131.
6. WATANABE-FUKUNAGA R., BRANNAN C.I., COPELAND N.G., JENKINS N.A. & NAGATA S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314.
7. SUDA T., TAKAHASHI T., GOLSTEIN P. & NAGATA S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169.
8. ARASE H., ARASE N. & SAITO T. (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181, 1235.
9. ALLEN R.D., MARSHALL J.D., ROTHS J.B. & SIDMAN C.L. (1990) Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med 172, 1367.
10. KAYAGAKI N., YAMAGUCHI N., NAGAO F. et al. (1997) Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci USA 94, 3914.
11. KOBATA T., YAGITA H., MATSUDA H. et al. (1990) Expression and function of a 90-kilodalton homodimeric molecule (10D1 antigen) on human thymocytes. J Immunol 145, 1053.
12. KAYAGAKI N., KAWASAKI A., EBATA T. et al. (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182, 1777.
13. SEINO K., KAYAGAKI N., BASHUDA H., OKUMURA K. & YAGITA H. (1996) Contribution of Fas ligand to cardiac allograft rejection. Int Immunol 8, 1347.
14. GAVRICH Y., SHERMAN Y. & BEN-SASSON S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119, 493.
15. CHU J.L., RAMOS P., ROSENDORFF A. et al. (1995) Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-vs.-host disease-like wasting syndrome. J Exp Med 181, 393.
16. NISHIMURA Y., ISHII A., KOBAYASHI Y., YAMASAKI Y. & YONEHARA S. (1995) Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol 154, 4395.
17. + T cells. Nature 376, 181.
18. MACDONALD G.C., KAKKANAIAH V.N., SOBEL E.S., COHEN P.L. & EISENBERG R.A. (1995) In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras. J Immunol 154, 444.
19. SOBEL E.S., KAKKANAIAH V.N., KAKKANAIAH M., COHEN P.L. & EISENBERG R.A. (1995) Co-infusion of normal bone marrow partially corrects the gld T-cell defect. J Immunol 154, 459.
20. JACOBSON B.A., PANKA D.J., NGUYEN K-A., ERIKSON J., ABBAS A.K. & MARSHAK-ROTHSTEIN A. (1995) Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3, 509.
21. + T cells in MRL-lpr/lpr mice. J Immunol 150, 3651.
22. GIESE T. & DAVIDSON W.F. (1994) Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J Immunol 152, 2000.
23. + thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 180, 423.
24. + thymocytes by the anti-Fas antibody. J Exp Med 181, 485.
25. WEIH F., RYSECK R-P., CHEN L. & BRAVO R. (1996) Apoptosis of nur 77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc Natl Acad Sci USA 93, 5533.
26. SINGER G.G. & ABBAS A.K. (1994) The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365.
27. MOUNTZ J.D., SMITH T.M. & TOTH K.S. (1990) Altered expression of self-reactive T cell receptor Vβ regions in autoimmune mice. J Immunol 144, 2159.
28. SIDMAN C.L., MARSHALL J.D. & BOEHMER H.V. (1992) Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur J Immunol 22, 499.
29. WU J., WILSON J., HE J., XIANG L., SCHUR P.H. & MOUNTZ J.D. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98, 1107.